Recycling Apparent Waste Into Biologicals: The Case of Umbilical Cord Blood in Italy and Spain
暂无分享,去创建一个
P. Rebulla | D. Prati | S. Pupella | S. Querol | V. de Angelis | J. Delgadillo | Vincenzo de Angelis
[1] P. Korrapati,et al. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells , 2021, Biotechnology Letters.
[2] K. Rezvani,et al. Optimal umbilical cord blood collection, processing and cryopreservation methods for sustained public cord blood banking. , 2021, Cytotherapy.
[3] A. Vilarrodona,et al. Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties , 2021, Scientific Reports.
[4] J. Larghero,et al. Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC) , 2021, Bone Marrow Transplantation.
[5] P. Rubinstein,et al. The wider perspective: cord blood banks and their future prospects , 2021, British journal of haematology.
[6] A. Madrigal,et al. Predictive analytics and cord blood banking: toward utilization-based unit selection. , 2021, Cytotherapy.
[7] A. Scaradavou. Cord blood beyond transplantation: can we use the experience to advance all cell therapies? , 2021, British journal of haematology.
[8] S. Querol,et al. Feasibility of umbilical cord blood as a source of red blood cell transfusion in preterm infants. , 2020, Blood transfusion = Trasfusione del sangue.
[9] B. Carducci,et al. Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation. , 2020, Blood transfusion = Trasfusione del sangue.
[10] M. Massara,et al. Use of cord blood platelet gel to enhance healing of deep surgical site dehiscences after peripheral bypass. , 2020, Regenerative medicine.
[11] S. Gómez,et al. Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow Donor Association Cord Blood Working Group , 2020, Stem cells translational medicine.
[12] P. Rebulla,et al. Clinical evaluation of allogeneic eye drops from cord blood platelet lysate. , 2020, Blood transfusion = Trasfusione del sangue.
[13] P. Rebulla,et al. Efficacy of allogeneic cord blood platelet gel on wounds of dystrophic epidermolysis bullosa patients after pseudosyndactyly surgery , 2020, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[14] E. Lopriore,et al. Allogeneic cord blood transfusions for extremely preterm neonates: an extremely promising proof of concept , 2020, British journal of haematology.
[15] P. Chiusolo,et al. Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB‐TrIP study , 2020, British journal of haematology.
[16] Luciano Rodríguez,et al. Cord Blood Platelet Rich Plasma Derivatives for Clinical Applications in Non-transfusion Medicine , 2020, Frontiers in Immunology.
[17] C. Azqueta,et al. Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application. , 2020, Blood transfusion = Trasfusione del sangue.
[18] A. Carnevali,et al. Umbilical Cord Blood and Serum for the Treatment of Ocular Diseases: A Comprehensive Review , 2020, Ophthalmology and Therapy.
[19] N. Mastrodonato,et al. First endocavitary treatment with cord blood platelet gel for perianal fistula. , 2020, Regenerative medicine.
[20] S. Querol,et al. Rapid review: next generation of cord blood banks; transplantation and beyond , 2019, Transfusion.
[21] J. Wagner,et al. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives , 2019, Bone Marrow Transplantation.
[22] L. Teofili. Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine , 2019, Mediterranean journal of hematology and infectious diseases.
[23] P. Rebulla,et al. Umbilical Cord Blood as a Source of Novel Reagents and Therapeutics , 2019, Perinatal Stem Cells.
[24] G. Vento,et al. Umbilical cord blood as a source for red‐blood‐cell transfusion in neonatology: a systematic review , 2018, Vox sanguinis.
[25] S. Bisti,et al. Topical Treatment with Cord Blood Serum in Glaucoma Patients: A Preliminary Report , 2018, Case reports in ophthalmological medicine.
[26] S. Chauhan,et al. Use of Autologous Umbilical Cord Blood Transfusion in Neonates Undergoing Surgical Correction of Congenital Cardiac Defects: A Pilot Study , 2018, Annals of cardiac anaesthesia.
[27] S. Carossa,et al. Cord blood platelet gel alone or in combination with photobiomodulation therapy for the treatment of oral ulcerations in patients with epidermolysis bullosa: A pilot clinical comparative study , 2018, Photodermatology, photoimmunology & photomedicine.
[28] J. Madrigal,et al. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma , 2018, Front. Immunol..
[29] E. Campos,et al. Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[30] P. Rebulla,et al. Cord blood platelet gel for the treatment of inherited epidermolysis bullosa. , 2018, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[31] M. Franchini,et al. A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network. , 2018, Blood transfusion = Trasfusione del sangue.
[32] A. Vlahou,et al. Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells , 2018, Bioengineering.
[33] G. Vento,et al. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity , 2018, Eye.
[34] P. Neema. In Response to “Use of Autologous Umbilical Cord Blood Transfusion in Neonates Undergoing Surgical Correction of Congenital Cardiac Defects: A Pilot Study” , 2018, Annals of cardiac anaesthesia.
[35] M. Massara,et al. Efficacy of cord blood platelet gel application for enhancing diabetic foot ulcer healing after lower limb revascularization. , 2017, Seminars in vascular surgery.
[36] Paolo Rebulla,et al. Impressive tissue regeneration of severe oral mucositis post stem cell transplantation using cord blood platelet gel , 2017, Transfusion.
[37] F. V. van Alphen,et al. Differences between Platelets Derived from Neonatal Cord Blood and Adult Peripheral Blood Assessed by Mass Spectrometry. , 2017, Journal of proteome research.
[38] Marzieh Ebrahimi,et al. Umbilical Cord Blood Platelet Lysate as Serum Substitute in Expansion of Human Mesenchymal Stem Cells , 2017, Cell journal.
[39] M. Fresina,et al. Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study , 2017, Cornea.
[40] M. Steurer,et al. Platelet gel: a new therapeutic tool with great potential. , 2017, Blood transfusion = Trasfusione del sangue.
[41] J. Kurtzberg. A History of Cord Blood Banking and Transplantation , 2017, Stem cells translational medicine.
[42] R. Pandey,et al. Comparison of Amniotic Membrane Transplantation and Umbilical Cord Serum in Acute Ocular Chemical Burns: A Randomized Controlled Trial. , 2016, American journal of ophthalmology.
[43] Lello Zolla,et al. Proteomic characterization of platelet gel releasate from adult peripheral and cord blood , 2016, Proteomics. Clinical applications.
[44] E. Parati,et al. Osteogenic differentiation of adipose tissue-derived mesenchymal stem cells cultured on a scaffold made of silk fibroin and cord blood platelet gel. , 2016, Blood transfusion = Trasfusione del sangue.
[45] P. Rebulla,et al. Multicentre standardisation of a clinical grade procedure for the preparation of allogeneic platelet concentrates from umbilical cord blood. , 2016, Blood transfusion = Trasfusione del sangue.
[46] Elisa Montelatici,et al. Extensive Characterization of Platelet Gel Releasate from Cord Blood in Regenerative Medicine , 2015, Cell transplantation.
[47] Gregory Katz,et al. Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks , 2015, PloS one.
[48] J. Madrigal,et al. Umbilical cord blood plasma contains soluble NKG2D ligands that mediate loss of natural killer cell function and cytotoxicity , 2015, European journal of immunology.
[49] K. Maitland,et al. Safety and efficacy of allogeneic umbilical cord red blood cell transfusion for children with severe anaemia in a Kenyan hospital: an open-label single-arm trial , 2015, The Lancet. Haematology.
[50] K. Yoon. Use of Umbilical Cord Serum in Ophthalmology , 2014, Chonnam medical journal.
[51] C. Romagnoli,et al. Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants , 2014, Neonatology.
[52] E. Erdem,et al. Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects. , 2014, International journal of ophthalmology.
[53] P. Rebulla,et al. Pleural tissue repair with cord blood platelet gel. , 2014, Blood transfusion = Trasfusione del sangue.
[54] E. Campos,et al. Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels. , 2014, Blood transfusion = Trasfusione del sangue.
[55] Texto Consolidado,et al. Real Decreto 1345/2007, de 11 de octubre, por el que se regula el procedimiento de autorización, registro y condiciones de dispensación de los medicamentos de uso humano fabricados industrialmente , 2013 .
[56] Carlo Petrini,et al. Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives , 2012, Journal of blood medicine.
[57] K. Maitland,et al. The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya , 2012, Transfusion.
[58] A. Ip,et al. Trends in cord blood banking. , 2012 .
[59] A. Brand,et al. Processing cord blood from premature infants into autologous red‐blood‐cell products for transfusion , 2011, Vox sanguinis.
[60] P. Rebulla,et al. Platelet gel from cord blood: A novel tool for tissue engineering , 2010, Platelets.
[61] A. Brand,et al. The use of cord blood for transfusion purposes: current status , 2009, Vox sanguinis.
[62] F. Walther,et al. A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity , 2008, Transfusion.
[63] Víctor M. Moralo Iza. Consideraciones en torno al abastecimiento del mercado, suministro de medicamentos y continuidad del servicio a la luz del artículo 2 de la Ley 29/2006, de 26 de julio, de Garantías y Uso Racional de los Medicamentos y Productos Sanitarios , 2007 .
[64] N. Bhattacharya. Placental umbilical cord whole blood transfusion to combat anemia in the background of tuberculosis and emaciation and its potential role as an immuno-adjuvant therapy for the under-resourced people of the world. , 2006, Clinical and experimental obstetrics & gynecology.
[65] M. Chettri,et al. A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. , 2001, Clinical and experimental obstetrics & gynecology.
[66] J. Stockman,et al. Anemia of prematurity. , 1975, Clinics in perinatology.